Krishna Vaddi Buys 100,000 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD) Stock
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Get Free Report) CEO Krishna Vaddi acquired 100,000 shares of Prelude Therapeutics stock in a transaction that occurred on Wednesday, December 18th. The stock was bought at an average price of $0.93 per share, with a total value of $93,000.00. Following the purchase, the chief executive officer now directly owns […]
More Stories
SigmaTron International (NASDAQ:SGMA) Releases Quarterly Earnings Results
SigmaTron International (NASDAQ:SGMA – Get Free Report) released its quarterly earnings results on Friday. The technology company reported ($1.55) earnings...
Sudan’s El Fasher siege: UN humanitarians killed as refugee crisis intensifies
The ongoing conflict in Sudan - particularly around besieged El Fasher – and a growing refugee crisis on the South...
Severin Hacker Sells 10,000 Shares of Duolingo, Inc. (NASDAQ:DUOL) Stock
Duolingo, Inc. (NASDAQ:DUOL – Get Free Report) insider Severin Hacker sold 10,000 shares of the business’s stock in a transaction...
Royal Helium (CVE:RHC) Shares Down 16.7% – Here’s What Happened
Royal Helium Ltd. (CVE:RHC – Get Free Report) fell 16.7% during mid-day trading on Friday . The company traded as...
Boston Beer (NYSE:SAM) Issues FY 2024 Earnings Guidance
Boston Beer (NYSE:SAM – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided EPS guidance...
SharkNinja (NYSE:SN) Shares Down 4.7% – What’s Next?
SharkNinja, Inc. (NYSE:SN – Get Free Report) fell 4.7% during mid-day trading on Wednesday . The company traded as low...